Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$217K Hold
3,220
0.2% 161
2026
Q1
$202K Sell
3,220
-780
-20% -$54.3K 0.19% 200
2025
Q4
$265K Hold
4,000
0.25% 168
2025
Q3
$269K Hold
4,000
0.2% 196
2025
Q2
$349K Hold
4,000
0.21% 190
2025
Q1
$273K Buy
+4,000
New +$326K 0.19% 230

Other funds holding DXCM

Corient IA's DXCM Position: Q2 2026 in Review

Corient IA held its DexCom (DXCM) position steady in Q2 2026 at 3,220 shares worth $217K. The position accounts for 0.2% of the portfolio, ranked #161.

Corient IA first reported a position in DXCM in Q1 2025 and has held it in 6 quarters since. The position peaked at $349K in Q2 2025. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Corient IA held 3,220 shares of DexCom worth $217K as of Q2 2026.
  • Corient IA left its DexCom share count unchanged in Q2 2026.
  • DexCom made up 0.2% of Corient IA's portfolio in Q2 2026, its #161 holding.
  • Corient IA first reported a position in DexCom in Q1 2025 and has held it in 6 quarters since.
  • Corient IA's DexCom position peaked at $349K in Q2 2025.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Corient IA's 13F filing for Q2 2026, filed 12 Aug 2026.